News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Karikó and Weissman were celebrated at several days of ceremonies and festivities in Sweden, two months after first learning the news.
Serpex Medical leverages the power of steerable instruments to enable greater precision and access to improve the diagnosis and treatment of lung cancer.
On December 5th, 2023, PCI hosted its annual Celebration of Innovation, where special awards were presented for exceptional commercialization accomplishments and to celebrate Penn innovators.
The goal of this innovative technology is to use the microrobots to assist in repairing peripheral nerves.
By obtaining samples from a wide-cross section of humanity, researchers are able to cross-reference participants’ DNA with their health records and identify genetic variants for a range of diseases.
A new biologic “patch” that is activated by a person’s natural motion has the potential to fix herniated discs in people’s backs, according to researchers at Penn Medicine and the CMC VA Medical Cente
Having received a Study May Proceed notification from the FDA, Carisma plans to initiate a Phase 1 study in the months to come and to treat the first patient in the first half of 2024.
Technical.ly published an article about the future of the growth of the life sciences in Philadelphia, highlighting Penn’s role in the development of the city as a strong tech hub.
During the program, Kamna Giare-Patel, CEO of Cerespectus and Thomas H., CEO of Peroxitech, shared their startup journeys and discussed their companies.
According to the report, Penn ranked within the top five largest research & development expenditures of US universities in 2021.